pharmaceutical investing CMS Grants Progenics New Technology Add-On Payment for Inpatient Use of AZEDRA
pharmaceutical investing Progenics Pharmaceuticals Doses First Patient in Phase 2 Clinical Study of 1095 Radiotherapy
pharmaceutical investing Progenics Pharmaceuticals and ROTOP Pharmaka GmbH Announce European Collaboration
pharmaceutical investing Progenics Acquires AZEDRA® (iobenguane I 131) Radiopharmaceutical Manufacturing Facility
pharmaceutical investing Progenics Reports Results of Phase 2/3 Trial of PSMA PET Imaging Agent PyL for the Detection of Prostate Cancer
Blue Jay Gold Announces Arrival of LithologIQ Hyperspectral Core Scanning System at the Steller Project
Metalsource Mining Continues to Define High Grade Polymetallic Core at Silver Hill with 33 Metre down Plunge Step Out
Star Copper Expands Copper-Gold Portfolio with Two Advanced District-Scale Exploration Assets in British Columbia
